NCT05262595 - A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

August 29, 2022

Study Completion Date

September 5, 2022

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

NNC0471-0119 A

"NNC0471-0119 administered once via an insulin pump as one bolus dose on top of a continuous basal rate.~The study will last 1-4 months"

DRUG

NNC0471-0119 B

"NNC0471-0119 administered once via an insulin pump as one bolus dose on top of a continuous basal rate.~The study will last 1-4 months"

DRUG

NNC0471-0119 D

"NNC0471-0119 administered once via an insulin pump as one bolus dose on top of a continuous basal rate.~The study will last 1-4 months"

DRUG

Faster aspart

"Faster aspart administered once via an insulin pump as one bolus dose on top of a continuous basal rate.~The study will last 1-4 months"

Trial Locations (1)

Novo Nordisk Investigational Site, Graz